Results 171 to 180 of about 23,676 (191)

Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights. [PDF]

Pharmaceuticals (Basel)
La Monica G, Bono A, Alamia F, Tocco D, Pizzolanti G, Lauria A, Martorana A.   +6 more
europepmc   +1 more source

Targeting Oncogenic Gene Fusions in Lung Cancer. [PDF]

Cancer J
Nie Y, Wilson FH.
europepmc   +1 more source

The combination of pralsetinib and bevacizumab enhances antitumor activity against KIF5B-RET lung cancer via PI3K/AKT pathway. [PDF]

J Thorac Dis
Wang X, Yuan G, Cong L, Song Z, Lin L, Cao Z.   +5 more
europepmc   +1 more source

Precision Oncology in Non-Small Cell Lung Cancer: Integrating Molecular Diagnostics, Targeted Therapies, and Resistance Mechanisms. [PDF]

Genes (Basel)
Litkowska A, Wojtas J, Nadulska K, Kurec G, Burdan O, Krawczyk PA.   +5 more
europepmc   +1 more source

Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies. [PDF]

Oncol Res
Cojocaru C, Costuleanu M, Petriș OR, Cojocaru R, Vasîncu D, Cojocaru E.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Discovery of 3,5-diaryl-1-pyrazol-based ureas as potent RET inhibitors

European Journal of Medicinal Chemistry, 2023
Can-Hui Zheng, Qian Cai
exaly  

Recent Developments of RET Protein Kinase Inhibitors With Diverse Scaffolds As Hinge Binders

Future Medicinal Chemistry, 2021
Zhao-Peng Liu, Wang Chen, Cong-Cong Jia
exaly  

1-Methyl-3-((4-(quinolin-4-yloxy)phenyl)amino)-1-pyrazole-4-carboxamide derivatives as new rearranged during Transfection (RET) kinase inhibitors capable of suppressing resistant mutants in solvent-front regions

European Journal of Medicinal Chemistry, 2022
Ke Ding, Xiaomei Ren, Zheng-Chao Tu
exaly  

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

Annals of Oncology, 2020
Sai-Hong Ou, J F Gainor, L J Wirth
exaly